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Introduction
Helicobacter pylori (H. pylori) plays an essential role in the development of gastroduodenal diseases, such as chronic 
atrophic gastritis, peptic ulcers (PUs), MALT-lymphoma, 
and gastric cancer (GC).1 GC is the fourth most common cancer 
and second leading cause of cancer-related deaths worldwide.2 The 
bacterium genotypes could determine the outcome of infection 
when combined with both environmental and host factors.3 A re-
cent study has shown that H. pylori infection, although strongly 
associated with the risk of GC, does not increase all-cause mortal-
ity and may be protective against lung cancer and stroke.4 There-
fore, it is essential to determine which strains of H. pylori could 
increase the risk of GC. One independent H. pylori locus that is 
correlated with increased risk of disease is vacuolating cytotoxin A 
(vacA) which encodes the secreted toxin VacA.5 Considerable dif-
ferences in vacuolating activities are observed between H. pylori 
strains. This variation is attributed to the vacA gene polymorphisms 
within the signal (s), s1 or s2; middle (m), m1 or m2; and the more 
???????????????????????????????????????????????????????2 The i region 
plays a functional role in vacuolating activity and is strongly asso-
ciated with gastric adenocarcinoma.6, 7 This association is indepen-
dent of and larger than the associations of vacA s- or m-type or cag 
status with gastric adenocarcinoma. Recently, an 81 bp deletion 
???????? ???????? ???? ?? ???? ?? ???????? ???? ????? ??????????? ????
termed the deletion (d) region, as d1 (no deletion) or d2 (with dele-
tion). The d1 type of the vacA gene is strongly associated with 
?????????????????????????????????????????????????????????????????-
trum and the corpus. Thus, the d region genotype is proposed to be 
an important risk locus for GC in Western strains.8 The cytotoxin-
associated gene A, cagA, is the other putative virulence factor of 
the bacterium which is much more likely to be associated with the 
development of GC.9,10 The ulcer-associated H. pylori gene, iceA1, 
which is induced by contact with the epithelium is also clinically 
relevant because the strains harboring this genotype are associated 
with the development of PUs.11,12 The other virulence gene that 
presents in some H. pylori strains is babA2 whose product is a 
blood-group antigen binding adhesion. It mediates adherence of H. 
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????????????? ????? ????????????? ?? ??????????
pylori to Lewis b (blood group antigen) in the human gastric epi-
thelial cells.13? ????????????????????????????????????????????????-
lation between the presence of the babA2 gene and the develop-
ment of atrophic gastritis or GC.14,15 
GC incidence is high in Iran, with age-standardized rates (ASRs) 
of 26.1/105 for males and 11.1/105???????????????????????????????????
of cancer-related deaths in males and the third cancer after breast 
and colorectal cancers in females.16,17 There is strong evidence of 
increased risk of GC in populations with higher rates of H. pylori 
infection.18 Iran is a country with a high prevalence of H. pylori 
infection (69%).19 The highest frequency (89%) is reported from 
Ardabil, a Northwestern province of Iran, where greater than 90% 
of adults aged 40 or over suffer from chronic gastritis related to 
H. pylori infection; GC is the most common malignancy (31%) 
with ASRs of 51.8/105 for males and 24.9/105 for females.20–22 
The incidence of GC in the Northern districts of Iran, particularly 
Guilan, Mazanderan, and Golestan Provinces located in Caspi-
an Sea littoral has been reported to be considerably high (ASRs 
>20/105), whereas it is low in the Southern regions of Iran, such 
as Khuzestan, Kerman, and Yazd provinces (ASRs <10/105).16,23–25 
However, the actual role of bacterial/host factors and geographic 
or ethnic differences in the incidence of GC in Iran, especially in 
the high incidence Northern latitude is not clear. In a recent study, 
we have indicated that the H. pylori status in Iran is strongly in-
???????????????????????????????????????????????????????????????
ethnic and geographic differentiation has been well persevered 
within the country.26 Iranian H. pylori strains are similar to others 
isolated from Western Eurasia and can be placed in the previously 
described HpEurope population. It has been shown that the geo-
graphic differences in the cancer risk deriving from H. pylori infec-
tion could be explained by the phylogeographic origin of H. pylori 
strains. The strains with European origin are strongly predictive 
of increased premalignant histological lesions and epithelial DNA 
damage.27 Although Iranian H. pylori strains represent European 
phylogeographic origin, the 2- to 10-fold difference in the inci-
dence of GC between the Northwestern-Northern and Southern 
regions of Iran is controversial. One hypothesis is the geographic 
?????????????????????????????????????H. pylori virulence genes in Iran, 
??????????????????????????????????????????????????????????????????
pressures.
The aim of the present study was to determine: i) Is there any 
?????????????????????????????????????H. pylori virulence genes be-
tween Iranian populations from different geographic locations of 
Iran, when comparing isolates from high and low incidence areas 
of GC? ii) Is there a north-south cline in the allelic frequency of H. 
pylori virulence genes in Iran?
Materials and Methods
Patients
A total of 280 patients participated in the study from 2007–2009. 
Patients referred to the reference endoscopy units in ten districts of 
Iran that included the high and low incidence areas for GC (Figure 
1). Biopsies were taken from patients who were of Iranian nation-
ality, had the same place of birth and residency, and who gave the 
same ethnic/linguistic origin for both of their parents and for all 
four of their grandparents. 
The study was approved by the Ethics Committee of the Diges-
tive Diseases Research Institute, Shariati Hospital, Tehran Univer-
sity of Medical Sciences based on the ethical principles of human 
research and experimentation expressed in the Declaration of Hel-
sinki. All subjects underwent endoscopies as part of their treatment 
process. Informed consent for participation in the study was given 
by each subject in writing. The structured ethnic/linguistic ques-
tionnaire was completed for each subject by direct interview. 
Bacterial isolates and cultivation
A total of 138 H. pylori isolates were obtained from gastric bi-
Figure 1. Detailed map showing highlighted geographical locations where H. pylori isolates 
were obtained. The high and low incidence areas for gastric cancer (GC) are shown.
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H. pylori?????????? ? ?????????? ?????
opsy cultures of the patients. Gastric biopsies were cultured on 
selective Brucella agar (Merck, Germany) that contained 10% 
blood, vancomycin (10 mg/mL; Zakaria, Iran), trimethoprim (5 
mg/mL; MP Biomedicals, France), and amphotericin B (4 mg/
mL; Bristol-Myers Squibb, USA). Plates were incubated at 37?C 
under microaerobic conditions and examined for visible bacterial 
???????????????????????????????????????????????????????????????H. 
pylori according to Gram’s stain, as Gram-negative spiral forms, 
in addition to positive urease, oxidase and catalase tests, as well as 
????????????????????H. pylori 16S rDNA.28 We performed single 
colony isolation in order to ensure that each strain consisted of only 
a single genotype. Bacterial isolates were harvested in brain heart 
infusion broth (Merck, Germany) enriched with 20% glycerol and 
10% inactivated horse serum and stored at -70?C .
Genes Primers ????????????? ??? Size of PCR products (bp)
Optimized annealing 
temperature (°C) References
16S rDNA HP1 GCAATCAGCGTCAGTAATGTTC 519 56 28
HP2 GCTAAGAGATCAGCCTATGTCC
vacA
s1/-s2 s1a-F GTC AGC ATC ACA CCG CAA C s1a: 190 54 46
s1a-R CTG CTT GAA TGC GCC AAA C
s1b-F AGC GCC ATA CCG CAA GAG s1b: 187 54
s1b-R CTG CTT GAA TGC GCC AAA C
s2-F GCT AAC ACG CCA AAT GAT CC s2: 199 54
s2-R CTG CTT GAA TGC GCC AAA C
m1/-m2 VAG-F CAA TCT GTC CAA TCA AGC GAG GCG m1: 570 56 47
VAG-R GCG TCT AAA TAA TTC CAA GG m2: 645
i1-/i2 VAC F1 GTTGGGATTGGGGGAATGCCG i1: 426 53 6
C1R TTAATTTAACGCTGTTTGAAG
VACF2 GTTGGGATTGGGGGAATGCCG i2: 432 53
C2R GATCAACGCTCTGATTTGA
d1/-d2 VAS-5 F ACTAATATTGGCACACTGGATTTG d1: 367–379 45 8
VAGF-R CTCGCTTGATTGGACAGATTG d2: 298
mD1-F AGGTYATTAACCCACCCAA d1: 223 45 This study
md1-R CTCGCTTGATTGGACAGATTG
cagA
N-terminus cagAN-F CCATTTTAAGCAACTCCATAAACC 413 56 48
cagAN-R CTGCAAAAGATTGTTTGGCAGA
Central region cagAC-F GGCAATGGTGGTCCTGGAGCTAGGC 243 55 48
cagAC-R GGAAATCTTTAATCTCAGTTCGG
C-terminus CAG1 ACC CTAGTC GGT AAT GGG TTA 591–856 50 49
CAG2 GTA ATT GTC TAG TTT CGC
babA
babA2 BABA2F AATCCAAAAAGGAGAAAAAGTATGAAA 832 or 601 55 42, 46
BABA2R TGTTAGTGATTTCGGTGTAGGACA
BABA2R607 CTTTGAGCGCGGGTAAGC 54
iceA
iceA1 iceA1-F GTGTTTTTAACCAAAGTATC 247 48 50
iceA1-R CTATAGCCASTYTCTTTGCA
iceA2 iceA2-F GTTGGGTATATCACAATTTAT 229 or 334 48
IceA2-R TTRCCCTATTTTCTAGTAGGT
Table 1. Oligonucleotide primers used for PCR.
Allele frequency (%)
Provinces Strains(N) vacA s1 vacA s2 vacA m1 vacA m2 vacA i1 vacA i2 vacA d1 vacA d2 cagA + babA2 iceA1 iceA2 iceA1/2
Ardabil 28 27 (96.4) 1 (3.6) 8 (28.6) 20 (71.4) 16 (57.1) 12 (42.9) 15 (53.6) 13 (46.4) 20 (68.9) 9 (32.1) 24 (85.7) 19 (67.8) 15 (53.5)
Mazanderan 13 12 (92.3) 1 (7.7) 7 (53.8) 6 (46.2) 9 (69.2) 4 (30.8) 9 (69.2) 4 (30.8) 11 (84.6) 5 (34.4) 10 (76.9) 6 (46.1) 3 (23.0)
Kurdistan 10 9 (90.0) 1 (10.0) 2 (20.0) 8 (80.0) 4 (40.0) 6 (60.0) 3 (30.0) 7 (70.0) 4 (40.0) 5 (50.0) 3 (30.0) 8 (80.0) 1 (20.0)
Lorestan 10 9 (90.0) 1 (10.0) 2 (20.0) 8 (80.0) 5 (50.0) 5 (50.0) 5 (50.0) 5 (50.0) 7 (70.0) 3 (30.0) 10 (100) 4 (40.0) 4 (40.0)
Kermanshah 11 10 (90.9) 1 (9.1) 1 (9.1) 10 (90.9) 4 (36.4) 7 (63.6) 3 (27.3) 8 (72.7) 8 (72.7) 3 (27.3) 8 (72.7) 9 (81.8) 6 (54.5)
Khorasan 
Razavi 15 15 (100) 0 (0.0) 1 (6.7) 14 (93.3) 3 (20.0) 12 (80.0) 3 (20.0) 12 (80.0) 9 (60.0) 9 (60.0) 13 (86.6) 5 (33.3) 3 (20.0)
Kohgiluyeh &
Boyerahmad 7 7 (100) 0 (0.0) 3 (42.9) 4 (57.1) 2 (28.6) 5 (71.4) 3 (42.9) 4 (57.1) 4 (57.1) 4 (57.1) 6 (85.7) 3 (42.8) 2 (28.5)
Khuzestan 22 22 (100) 0 (0.0) 5 (22.7) 17 (77.3) 6 (27.3) 16 (72.7) 5 (22.7) 17 (77.3) 14 (63.6) 10 (45.4) 17 (72.3) 7 (31.8) 2 (28.5)
Yazd 14 13 (92.9) 1 (7.1) 2 (14.3) 12 (85.7) 3 (21.4) 11 (78.6) 4 (28.6) 10 (71.4) 9 (68.3) 6 (42.8) 9 (64.3) 8 (57.1) 3 (21.4)
Hormozgan 8 7 (87.5) 1 (12.5) 3 (37.5) 5 (62.5) 4 (50.0) 4 (50.0) 5 (62.5) 3 (37.5) 5 (62.5) 2 (25.0) 6 (75.0) 4 (50.0) 2 (25.0)
Total 138 ?????????? ??????? ????????? ?????????? ????????? ????????? 55 (39.9) 83 (60.1) 91 (65.9) ????????? ?????????? ????????? ?????????
Table 2. Frequency of the vacA alleles and iceA1, iceA2, babA2, and cagA genes in H. pylori isolates from different geographic locations in Iran.
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DNA extraction and genotyping
DNA was extracted from H. pylori isolates with the Genomic 
????????????????????????????????????????????????????????????-
turer’s instructions. The bacterial genotypes; the vacA signal se-
quences, s1 (s1a or s1b) or s2; the middle (m1 or m2), intermediate 
(i1 or i2), and deletion regions (d1 or d2); and the iceA1, iceA2, 
babA2, and cagA genes were determined by PCR. Negative con-
trols included Escherichia coli???????????????????????????????
recruited primers are described in Table 1. PCR was performed 
?????????????????????????????????????????????????????????????-
??????????????????????????????????????????????????????????????
mM MgCl2, 2 U of Taq DNA polymerase (CinnaGen, Iran), 0.5 ?????????????? ??????????????????????????? ???? ????????????????
was performed over a total of 30 cycles. Each cycle consisted of 
the following steps: denaturation at 96?C  for 40 s, optimized an-
nealing temperature for each allele (Table 1) for 40 s, extension at 
72????????????????????????????????????????C  for 7 min. PCR prod-
ucts were electrophoresed and visualized by a UV transilluminator. 
Comparison of the PCR products of the vacA alleles and the iceA1, 
iceA2, babA2, and cagA genes with the molecular ladder revealed 
the bands’ sizes. The band sizes according to gene and allele are 
listed in Table 1.
??????????????????????????????vacA alleles and the iceA1, iceA2, 
babA2, and cagA????????????????????????????????????????????????
into the compatible site of the pTG19-T PCR cloning vector, and 
sequenced with both M13 forward and reverse primers using 
BigDye technology on an ABI3700XL DNA sequencer (Applied 
Biosystems). The BLAST program (http://www.ncbi.nlm.nih.gov) 
was used to match the nucleotide sequences with the published 
sequences in GenBank.
Statistical analysis
We used the hierarchical analyses of molecular variance (AMO-
VA) in GenAlEx 6.529 to determine whether the means of genetic 
variation in the allelic frequencies of bacterial virulence genes 
were all equal between the Iranian populations either from the en-
tire populations or those from the high and low incidence areas of 
GC. This model of analysis separates the total genetic variance into 
components attributable to different sources of variation. The sig-
????????? ??????????????? 999 random permutations. Pearson chi-
?????????2) and Fisher’s exact tests were used to determine whether 
the frequency of each gene/allele and their combinations differed 
between the Northwestern-Northern and Southern geographic re-
gions of Iran. The analysis was performed using SPSS v.14. A P 
value of < ???????????????????????????? ??????????? ????????????30 
in GenAlEx 6.5 to evaluate the relationship between genetic and 
geographic distance matrices. This test takes into account that the 
set of all pair-wise distances, genetic or spatial, is not independent. 
This test was performed when considering distance matrices be-
tween?????????????????????????????????????????????????????????????
tested using 999 random permutations.  
Results
We obtained a total of 138 H. pylori isolates from dyspeptic pa-
tients aged 17–90 years (mean age: 44.47 years). Of these, 69 were 
female.
Electrophoresis of the 16S rDNA PCR products from the 138 
H. pylori??????????????????????????????????????????????????the 
identity of isolates as H. pylori. Most isolates with the iceA2 al-
lele could be divided into two types according to the presence of 
repeated sequences of 105 nucleotides and whether PCR products 
were 229 bp (iceA2-1) or 334 bp (iceA2-2) long. Of 73 iceA2-pos-
itive isolates, 48 showed PCR products that were 229 bp whereas 
28 showed the PCR products of 334 bp. Only three of the isolates 
had both PCR products (229 bp and 334 bp), however none of 
??????????????????????????????????????????????????????????????con-
trol E. coli??????????????????????????????????????with the H. 
pylori???????????? ????
The vacA s1 allele was the most prevalent gene (94.9%, 131/138) 
compared with the vacA s2 allele (5.1%, 7/138). Of 131 vacA s1 
alleles, 127 (96.95%) were s1a and 4 (3.05%) were s1b. In the 
138 strains tested, vacA genotypes were present in the following 
percentages: m1 (24.6%, 34), m2 (75.4%, 104), d1 (39.9%, 55), d2 
(60.1%, 83), i1 (40.6%, 56), and i2 (59.4%, 82). The iceA1 gene 
was present in 76.8% (106/138) of strains, whereas the iceA2 gene 
was present in 52.9% (73/138). A number of strains showed both 
iceA1 and iceA2 genes, namely the iceA1/2 gene. The frequencies 
of the iceA1/2 and babA2 genes were 29.7% (41/138) and 40.6% 
(56/138), respectively. The cagA gene was the fourth most prev-
alent gene after vacA s1 (94.9%), iceA1 (76.8%), and vacA m2 
(75.4%), with a frequency of 65.9% (91/138). Table 2 shows the 
frequency of the virulence genes and alleles in different loci of the 
H. pylori isolates from different geographic locations in Iran. 
The individual AMOVA for the vacA d1, d2, i1, and i2, alleles 
as well as the iceA1 and iceA1/2 genes for 138 H. pylori isolates 
from the ten geographic regions of Iran ????????????????? ???????
of genetic differentiation among populations (P < 0.05). The test 
showed that a considerable portion of the total genetic variation 
resulted from differences between individual H. pylori isolates 
within-populations, 91% for vacA i1 and iceA1, 90% for vacA i2, 
88% for vacA d1, and 93% for vacA d2 and iceA1/2, while the 
between-populations genetic variation accounted for the remain-
ing 9% (vacA i1 and iceA1), 10% (vacA i2), 12% (vacA d1), and 
7% (vacA d2 and iceA1/2). When the analysis was restricted to the 
Northwestern-Northern (Ardabil and Mazanderan) and Southern 
(Khuzestan and Yazd) regions of Iran, AMOVA for the vacA d1, 
d2, i1, and i2 alleles and iceA1/2 gene (but not iceA1) revealed 
?? ?????????? genetic difference among populations (P < 0.05). 
AMOVA statistics showed the distribution of genetic variance as 
88% and 83% within- and 12% and 17% between-populations for 
the vacA alleles (d1, d2, i1, and i2) and iceA1/2 gene, respectively. 
The results?????2 and Fisher’s exact tests showed a ?????????????
higher prevalence of the vacA d1 and i1 genotypes and iceA1/2 
gene among H. pylori isolates from the high incidence GC ar-
eas compared with those from low incidence areas in Iran [24/41 
(58.5%) vs. 9/36 (25.0%), 25/41 (61.0%) vs. 9/36 (25.0%), and 
iceA1/2: 18/41 (43.9%) vs. 5/36 (13.8%), respectively, P < 0.005; 
Table 3]. The results of analysis showed ?????????????????????????
in the distribution of the vacA s1, s2, m1, and m2 genotypes and 
iceA1, iceA2, babA2, and cagA genes among H. pylori isolates 
from high and low incidence GC areas (P > 0.05). 
The frequency of genotype combinations of the vacA d1/i1, vacA 
d1/iceA1, vacA d1/iceA1/2, vacA d1/cagA+, vacA i1/iceA1, vacA 
i1/iceA1/2, and vacA i1/cagA+ ???????????????????????????????H. 
pylori isolates from the high incidence areas of GC compared with 
those from the low incidence areas in Iran (P < 0.005; for the latter, 
P = 0.016). The genotype combinations of the vacA d2/i2, m2/d2, 
and m2/i2 were??????????????????? ????????????????????H. pylori 
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isolates from low incidence areas of GC compared with those from 
high incidence areas (P < 0.005; Table 4).
The results of Mantel’s test showed low correlation between 
genetic and geographic distances for the iceA1 (r = 0.098) and 
iceA1/2 (r = 0.074) genes among the ten districts (P < 0.05). No 
??????????? ??????????? was found between the genetic and geo-
graphic distances for the vacA alleles (s1, s2, m1, m2, i1, i2, d1, 
d2) and the iceA2, babA2, and cagA genes in Iran (P > 0.05). 
Discussion
In the present study we determined the distribution of H. pylori 
virulence genes/alleles between the high and low incidence areas 
for GC in Iran. The most prevalent genes were vacA s1a, iceA1, 
vacA m2, and cagA followed by vacA d2 and i2 genotypes and 
the iceA2 gene, respectively. The vacA m1, d1, and i1 genotypes 
and iceA1/2 and babA2 genes occurred at low and intermediate 
Table 3. Frequency of vacA alleles and iceA1, iceA2, babA2, and cagA genes in H. pylori isolates from Northwestern-Northern (NW-N) and 
Southern (S) geographic regions of Iran representing the high and low incidence of gastric cancer, respectively.
NW-N Iran† S Iran‡
Total (n???????????? ?
Genotypes High incidence areas for GC¶ (n??????No. (%)
Low incidence areas for GC
(n = 36) No. (%)
vacA d1/i1 21 (51.2) ???????? ?????????
vacA m1/i1 14  (34.1) 6 (16.7) 20 (26.0)
vacA m1/d1 15 (36.6) 7 (19.4) 22 (28.6)
vacA m1/babA2 6 (14.6) 4 (11.1) 10 (13.0)
vacA m1/iceA1 12 (29.3) 6 (16.7) 18 (23.4)
vacA m1/iceA1/2 5 (12.2) 0 (0.0) 5 (6.5)
vacA m1/cagA+ 14 (34.1) 7 (19.4) 21 (27.3)
vacA d1/babA2 11 (26.8) 6 (16.6) 17 (22.1)
vacA d1/iceA1 ????????? ???????? ?????????
vacA d1/iceA1/2 8 (19.5) 0 (0.0) ????????
vacA d1/cagA+ 23 (56.1) 8 (22.2) ?????????
vacA i1/babA2 10 (24.4) 4 (11.1) 14 (18.2)
vacA i1/iceA1 ????????? ???????? 26 (33.8)
vacA i1/iceA1/2 ????????? 0 (0.0) 10 (13)
vacA i1/cagA+ ????????? 8 (22.2) ?????????
iceA1/cagA+ 25 (61.0) 20 (55.6) 45 (58.4)
iceA1/2/cagA+ 9 (22.0) 3 (8.3) 12 (15.6)
iceA1/babA2 11 (26.8) 13 (36.1) 24 (31.2)
iceA1/2/babA2 4 (9.8) 4 (11.1) 8 (10.4)
vacA m1/i2 1 (2.4) 1 (2.8) 2 (2.6) 
vacA m2/i1 10 (24.4) 3 (8.3) 13 (16.9) 
vacA m2i2 16 (39.0) ?????????? ?????????
vacA m2/d1 9 (21.9) 2 (5.5) 11 (14.3) 
vacA m2/d2 ?????????? ?????????? ??????????
vacA d1/i2 3 (7.3) 3 (8.3) 6 (7.8)
vacA d2/i1 3 (7.3) 3 (8.3) 6 (7.8)
vacA d2/i2 ?????????? ?????????? ??????????
vacA m1/i1/cagA+ 13 (31.7) 6 (16.7) 19 (24.7)
vacA m1/i1/babA2 4 (9.8) 3 (8.3) 7 (9.1)
vacA m1/i1/iceA1 11 (26.8) 5 (13.9) 16 (20.8)
vacA m1/i1/iceA1/2 5 (12.2) 0 (0.0) 5 (6.5)
vacA m1/d1/babA2 5 (12.2) 4 (11.1) 9 (11.7)
vacA m1/d1/cagA+ 14 (34.1) 7 (19.4) 21 (27.3)
vacA m1/d1/iceA1 12 (29.3) 6 (16.7) 18 (23.4)
vacA m1/i1/d1 14 (34.1) 6 (16.7) 20 (26.0)
vacA m1/d1/iceA1/2 5 (12.2) 0 (0.0) 5 (6.5)
cagA+/babA2/iceA1 10 (24.4) 12 (33.3) 22 (28.6)
cagA+/babA2/iceA1/2 3 (7.3) 3 (8.3) 6 (7.8)
†Ardabil (NW Iran) and Mazanderan (N Iran), (Age-standardized rates, ASRs = 51.8/105 and 26.78/105, respectively); ‡Khuzestan and Yazd (S Iran), (ASRs 
< 10/105?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????P < 0.005; for 
vacA i1/cagA+, P = 0.016).
Table 4. Frequency of combinations of the vacA m1, i1, and d1 alleles and iceA1, babA2, and cagA genes in H. pylori isolates from Northwestern-
Northern (NW-N) and Southern (S) geographic regions of Iran representing the high- and low incidence of gastric cancer, respectively.
Allele frequency (%)
GC¶ 
incidence
Strains
(N) vacA s1 vacA s2 vacA m1 vacA m2 vacA i1 vacA i2 vacA d1 vacA d2 cagA+ cagA - babA2 iceA1 iceA2 iceA1/2
NW-N 
Iran
High† 41 39(95.1)
2  
(4.9)
15
(36.6)
26
(63.4)
25
(61.0)
16
(39.0)
24
(58.5)
17
(41.5)
31
(75.6)
10
(24.4)
14
(34.2)
34
(82.9)
25
(61.0)
18
(43.9)
S Iran
Low‡ 36 35(97.2)
1
(2.8)
7
(19.4)
29
(80.6)
9
(25.0)
27
(75.0)
9
(25.0)
27
(75.0)
23
(63.9)
13
(36.1)
16
(44.4)
26
(72.2)
15
(41.7)
5
(13.9)
Total ?? ??(96.1)
3
(3.9)
22
(28.6)
55
??????
??
??????
??
(55.8)
33
??????
??
?????
??
??????
23
9.9)
30
(39.0)
60
??????
??
(51.9)
23
(29.9)
¶GC= gastric cancer; †Ardabil (NW Iran) and Mazanderan (N Iran), (Age-standardized rates: ASRs = 51.8/105 and 26.78/105, respectively); ‡Khuzestan and 
Yazd (S Iran), (ASRs < 10/105)
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????????????? ????? ????????????? ?? ??????????
frequencies in Iran. The most predominant genotype combinations 
were iceA1/cagA+, vacA m2/d2, and vacA m2i2, respectively. 
BLAST analysis using the sequenced fragments of each gene/al-
lele from seven isolates showed that these sequences exclusively 
matched the corresponding sequences in H. pylori J99, 26695, 
60190, and Tx30a. 
Ogiwara et al. showed that in Western countries (n = 266) the 
frequencies for the vacA alleles were s1 (80.8%), m1 (64.3%), i1 
(71.8%), and d1 (74.1%) alleles and the vacA s1/m1/i1 (64.0%) 
and s1/m1/i1/d1 genotypes (64.0%). In Eastern countries (n = 
244), the frequencies were 100% (s1), 92.6% (m1), 97.5% (i1), 
98.0% (d1), 92.6% (vacA s1/m1/i1), and 92.6% (vacA s1/m1/
i1/d1).8 In Western countries, strains that harbored the vacA s1, 
m1, i1, or ??????????????????????????????????????????????????????
development of GC (adjusted ORs: 3.17, 10.65, 8.57, and 8.04, 
respectively). ???????? ????????????????????? ????????????????????-
relation between the vacA genotypes, clinical consequences and 
histopathological changes.8 A recent follow-up study performed on 
321 patients from a high-risk area of GC in Spain has shown that 
infection with cagA+/vacA s1/m1 strains was associated with the 
progression of gastric precancerous lesions (OR = 4.80) compared 
with those infected with strains that harbored the cagA-/vacA s2/
m2 genotype.31 In Iran, the frequencies of vacA s1, s2, m1, and 
m2 have been previously reported as 69.0%-80.3% (s1), 19.7%–
31.0% (s2), 30.7%–49.7% (m1), and 50.3%–69.3% (m2).6,32–36 
The present study also reported higher frequencies of vacA s1 and 
m2, of which the frequency of m2 was more than twice the rate re-
ported in both Western and Eastern countries. The relationship be-
tween H. pylori vacA genotypes, particularly the s1/m1/i1 alleles, 
and development of GC in Iran has been shown in several reports. 
This ?????????????????? ???????????????????????????????????develop-
ment of severe gastrointestinal diseases.6, 37 However, Siavoshi et 
?????????????????????????????????????????????????H. pylori vacA s 
and m region alleles to the types of gastritis, non-atrophy, atrophy, 
or intestinal metaplasia (IM) and severe forms of atrophy or IM in 
????????????????????????? ??patients.36
The iceA gene has two main allelic variants, iceA1 and iceA2. 
The iceA1 gene represents sequence homology with the Neisseria 
lactamica nla????????????????????????????????????????????? en-
donuclease. In contrast, the iceA2 gene has no homology with the 
nucleotide sequences of the known genes released in the EMBL/
GenBank database and its function remains unclear.12,38 H. pylori 
strains might acquire these genes by genetic exchange with other 
bacteria. However, there is no evidence showing that both the iceA1 
and iceA2 genes have been derived from a common ancestor.39 
Shiota et al. conducted a meta-analysis with a total of 5357 pa-
tients in order to determine the prevalence of the iceA1 gene and its 
relationship ??????????????????????????????????????????????????????
overall prevalence of iceA1 in Asian countries (64.6%, 1791/2771) 
compared to Western countries (42.1%, 935/2218; P < 0.0001). In 
contrast, the prevalence of iceA2 ??????????????????????????? ???-
ern countries (45.1%, 844/1871) than Asian countries (25.8%, 
651/2522; P < 0.0001). The presence of iceA1?????????????????-
related with PUs.12 In the present study, the prevalence of iceA1 
was 76.8%, whereas iceA2 was 52.9%. Both were substantially 
greater than rates reported from Western and Eastern countries. We 
showed the presence of both the iceA1 and iceA2 genes (iceA1/2) 
in the same strains (29.7%, 41/138). In most studies, the presence 
of both genes in the same strains might be explained by mixed in-
fection, for which strains that harbored the iceA1/2 genotype were 
excluded from the study.40 However, Gonzalez-Vazquez et al. have 
recently reported the presence of both the iceA1 and iceA2 genes in 
the same strains.41 In the present study, single colonies were used 
and genotyped. Each pair of primers was used ????????????????-
tion of the genes/alleles from all of the strains. Strains positive for 
the vacA i1 allele were also checked for the presence of the vacA i2 
allele. Therefore, there was no possibility of any mixed infection; 
the presence of the iceA1/2?????????? ?????????????
The frequency of the babA2 genotype in Western countries has 
been reported as 36%–72%, which was associated with the de-
velopment of GC.42,43 The frequency rate was 100% in Eastern 
countries, without a GC association.44 In Iran, the babA2 genotype, 
which frequency was 40.6%, strongly correlated with GC com-
pared to non-ulcer and ulcer patients (P = 0.0004).15 In the present 
study, the frequency rate was 40.6%; however, it could not differ-
entiate the H. pylori strains, particularly between the high and low 
incidence GC areas. The frequency of the cagA gene in Western 
and Eastern countries has been reported as more than 60% and 
95% with and without an association to GC, respectively.31, 45 A 
frequency of 65.9% in the present study is consistent with earlier 
reports, however its association with GC is still controversial in 
Iran.32,36 
We performed an individual AMOVA for the virulence genes/
alleles for 138 H. pylori isolates that were distributed into ten geo-
graphic regions in Iran. The AMOVA for the vacA d1, d2, i1, and i2 
alleles and iceA1 and iceA1/2 genes found ???????????????????????-
netic differentiation among populations. These results have shown 
that considerable variation in the virulence genes has been well 
preserved at the population level. When the analysis was restricted 
to the four districts that represented high (Ardabil and Mazan-
deran) and low (Khuzestan and Yazd) incidence areas for GC, the 
AMOVA for iceA1 did not show any differentiation between popu-
lations. The prevalence of the vacA d1, i1, and d1/i1 genotypes 
and iceA1/2 gene (but not iceA1?? ?????????????????higher (>2- or 
3-fold) among H. pylori isolates from the high (ASRs > 20/105; 
max. 51.8/105) than low incidence (ASRs < 10/105) areas for GC in 
Iran (P < 0.005). The vacA d1/iceA1/2 and vacA i1/iceA1/2 geno-
types and the cagA or iceA1 genes in combinations either with the 
vacA i1 or d1 alleles (vacA d1/iceA1, vacA d1/cagA+, vacA i1/
iceA1, and vacA i1/cagA+) showed???????????????????????????????
(>2- or 3-fold) in the high than low incidence GC areas. In contrast, 
the vacA d2/i2, m2/d2, and ?????? ??????????????? ?????????????
more prevalent (approximately 2-fold) in the low rather than high 
incidence areas (P < 0.005). These results have suggested that the 
H. pylori vacA d1/-i1 alleles could be considered risk biomarkers 
in the high incidence GC areas in Iran. The prevalence of the vacA 
s1(a) allele was very high and mimicked the pattern observed in 
Eastern countries, while the prevalence of the vacA m1, d1, and i1 
was low compared with both Western and Eastern countries.8 In ad-
dition, the vacA s1(a) allele showed a similar distribution between 
the high and low incidence areas in Iran therefore it could not dif-
ferentiate H. pylori strains between these areas with different GC 
incidence. In the high incidence areas, the distribution of the vacA 
m1(36.6%), m1i1 (34.1%), m1d1 (36.6%), m1/iceA1(29.3%), m1/
iceA1/2 (12.2%), and m1/cagA+ (34.1%)  genotypes were high 
compared to the low incidence areas, which had the following dis-
tributions: 19.4% (m1), 16.7% (m1i1), 19.4% (m1d1), 16.7% (m1/
iceA1), 0.0% (m1/icdA1/2), and 19.4% (m1/cagA+), however the 
??????????????????????????????????????????????????????????analyses, the 
iceA1/2 genotype has shown considerable impact in geographic 
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differentiation of the strains, particularly between the high and low 
incidence areas. Therefore, this genotype may be of importance 
as a new risk marker although its function is not clear. The rela-
tively small sample size might have a negative impact ????????????
????????????????????????????????????????????????????????????
the consistency and reliability of these results. 
We performed Mantel’s test to determine whether there was a 
north-south cline in the allelic frequency of H. pylori virulence 
genes in Iran. The results only showed a low correlation between 
the genetic and geographic distances for the iceA1 and iceA1/2 (but 
not vacA alleles, iceA2, babA2, and cagA) genes among the ten 
districts (r = 0.098 and 0.074, respectively, P < 0.05). The lack of, 
or weak trend, has indicated that these geographic differences in 
the distribution of the H. pylori virulence genes/alleles might be 
???????? ?????????????????????????????????????
In conclusion, the present study showed the determinant role of 
the H. pylori vacA d and i region genotypes and the iceA1/2 gene 
rather than the vacA s and m region genotypes and iceA1, iceA2, 
babA2, and cagA genes in the geographic differentiation of H. py-
lori strains in Iran. The presence of the vacA m2 genotype and 
cagA or iceA1 genes might not be considered as independent of 
the vacA d and i regions in the differentiation of H. pylori strains 
between high and low incidence GC areas in Iran. The presence of 
both the iceA1 and iceA2 genes (iceA1/2) in the same strains might 
be of importance as a new risk marker, although its function was 
not clear. There was a weak or no north-south cline in the allelic 
frequency of H. pylori virulence genes/alleles in Iran, which indi-
cated the likely presence of ???????????????????????????? ???????
proposed that the H. pylori vacA d1/-i1 genotypes, which are new 
determinants of GC, have great potential to differentiate H. pylori 
strains between the high and low incidence areas of GC in Iran.  
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